Synergistic activity of dual β-lactams against <i>Mycobacterium avium</i> complex
. These findings identify readily accessible β-lactam combinations that could be rapidly translated into new treatment strategies for refractory MAC pulmonary disease, addressing a critical unmet clinical need.
Authors
- Khalid M Dousa (ORCID: https://orcid.org/0000-0003-3272-7231)
- Sebastian G. Kurz
- Mary Nantongo (ORCID: https://orcid.org/0000-0003-0137-6248)
- Eunjeong Shin
- Robert A. Bonomo
- Steven M. Holland
- Barry N. Kreiswirth
Institutions
- National Institutes of Health (US)
- Yale University (US)
- Geriatric Research Education and Clinical Center (US)
- Louis Stokes Cleveland VA Medical Center (US)
- National Institute of Allergy and Infectious Diseases (US)
- Hackensack Meridian Health (US)
- Center for Discovery (US)
- Case Western Reserve University (US)
Publication Details
- Journal
- Microbiology Spectrum
- Published
- 2026-03-31
- DOI
- https://doi.org/10.1128/spectrum.04001-25
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Cystic Fibrosis Foundation